Charles River Laboratories Officer Files Form 144 for $308K Stock Sale
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Subscribe to track CRL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Filing Alert: Charles River Laboratories International, Inc. ($CRL) ⢠Insider: Shannon M. Parisotto (Officer) ⢠Proposed Sale: 981 Common shares (~$308,579.64) ⢠Estimated Price: ~$314.56 per share ⢠Acquisition Source: Stock Option Exercise (Cash payment to Issuer on 10/05/2026) ⢠Plan Date: Rule 10b5-1 adopted on 03/04/2026 ⢠Broker: UBS Financial Services, Inc.
Comprehensive Analysis
Executive Summary
On October 5, 2026, Shannon M. Parisotto, an Officer of Charles River Laboratories International, Inc. ($CRL), submitted a Form 144 notice disclosing an intention to sell 981 shares of Common Stock with an estimated aggregate market value of $308,579.64.
Transaction Details
- Security: Common Stock
- Shares to Sell: 981
- Aggregate Market Value: $308,579.64 (~$314.56/share)
- Acquisition: Acquired on October 5, 2026, via stock option exercise from the issuer with cash payment.
- Broker: UBS Financial Services, Inc.
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2026.
Prior Sales in Past 3 Months
In the preceding three months, the insider reported selling an aggregate of 10,799 shares across three transactions:
- 08/05/2026: 5,046 shares for $1,327,098.00
- 08/11/2026: 3,714 shares for $1,038,657.24
- 08/19/2026: 2,039 shares for $599,710.68
Significance & Market Context
This proposed sale represents a negligible fraction of Charles River Laboratories' 47,738,872 outstanding shares (<0.003%) and is part of a pre-established Rule 10b5-1 plan established in March 2026. Given the modest transaction size and scheduled nature of the option exercise and disposition, the trading significance is rated Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
